组织工程与重建外科杂志
組織工程與重建外科雜誌
조직공정여중건외과잡지
JOURNAL OF TISSUE ENGINEERING AND RECONSTRUCTIVE SURGERY
2015年
2期
64-66
,共3页
吴敏%任玉萍%徐逸%侯楷%随文文%王宁宁%吴毅平
吳敏%任玉萍%徐逸%侯楷%隨文文%王寧寧%吳毅平
오민%임옥평%서일%후해%수문문%왕저저%오의평
乳腺癌%保留皮肤的乳房腺体全切术%乳房重建%假体%生物膜
乳腺癌%保留皮膚的乳房腺體全切術%乳房重建%假體%生物膜
유선암%보류피부적유방선체전절술%유방중건%가체%생물막
Breast cancer%Skin-sparing mastectomy%Breast reconstruction%Prosthesis%Dermal matrices
目的:评价乳腺癌术后即刻应用假体和生物膜进行乳房Ⅰ期重建的临床效果。方法随访2012年至2014年28例保留皮肤的乳房腺体全切术(SSM)患者,其中Ⅰ期用硅胶假体置入胸大肌后生物膜重建乳房下皱襞的患者19例(A组);单纯硅胶假体置入,未使用生物膜的患者9例(B组)。比较两组患者术后1年内,假体外露、假体移位、血肿、包膜挛缩、感染和异物反应等并发症的发生率。结果 A组仅有1例发生血肿(5.26%),其他并发症均未发生;而B组有1例发生假体外露(11.11%)、2例发生假体移位(33.33%)、1例血肿(11.11%)、4例包膜挛缩(44.44%),未发生感染和异物反应。 B组假体移位和包膜挛缩率明显高于A组(P<0.05)。术后随访1年,所有病例均无乳腺癌局部复发和远处转移。结论联合应用假体和生物膜重建乳房,形态良好,满意度较高,并发症少,是SSM术后安全有效的乳房重建方法。
目的:評價乳腺癌術後即刻應用假體和生物膜進行乳房Ⅰ期重建的臨床效果。方法隨訪2012年至2014年28例保留皮膚的乳房腺體全切術(SSM)患者,其中Ⅰ期用硅膠假體置入胸大肌後生物膜重建乳房下皺襞的患者19例(A組);單純硅膠假體置入,未使用生物膜的患者9例(B組)。比較兩組患者術後1年內,假體外露、假體移位、血腫、包膜攣縮、感染和異物反應等併髮癥的髮生率。結果 A組僅有1例髮生血腫(5.26%),其他併髮癥均未髮生;而B組有1例髮生假體外露(11.11%)、2例髮生假體移位(33.33%)、1例血腫(11.11%)、4例包膜攣縮(44.44%),未髮生感染和異物反應。 B組假體移位和包膜攣縮率明顯高于A組(P<0.05)。術後隨訪1年,所有病例均無乳腺癌跼部複髮和遠處轉移。結論聯閤應用假體和生物膜重建乳房,形態良好,滿意度較高,併髮癥少,是SSM術後安全有效的乳房重建方法。
목적:평개유선암술후즉각응용가체화생물막진행유방Ⅰ기중건적림상효과。방법수방2012년지2014년28례보류피부적유방선체전절술(SSM)환자,기중Ⅰ기용규효가체치입흉대기후생물막중건유방하추벽적환자19례(A조);단순규효가체치입,미사용생물막적환자9례(B조)。비교량조환자술후1년내,가체외로、가체이위、혈종、포막련축、감염화이물반응등병발증적발생솔。결과 A조부유1례발생혈종(5.26%),기타병발증균미발생;이B조유1례발생가체외로(11.11%)、2례발생가체이위(33.33%)、1례혈종(11.11%)、4례포막련축(44.44%),미발생감염화이물반응。 B조가체이위화포막련축솔명현고우A조(P<0.05)。술후수방1년,소유병례균무유선암국부복발화원처전이。결론연합응용가체화생물막중건유방,형태량호,만의도교고,병발증소,시SSM술후안전유효적유방중건방법。
Objective To evaluate the clinical outcome of one-stage breast reconstruction with prosthesis and dermal matrices after skin-sparing mastectomy (SSM). Methods From 2012 to 2014, 28 cases suffered breast cancer were received one stage breast reconstruction after SSM, and were divided into group A and group B. The silicone prosthesis and dermal matrices was performed in group A (n=19) to reshape the breast and strengthen the inframammary fold, and silicone prosthesis without dermal matrices was used in group B (n=9). The incidence of complication was compared between two groups 1 year after operation. Results In group A, only 1 case (5.26%) with hematoma was observed. In group B, 1 case (11.11%) with prosthesis exposure, 3 cases (33.33%) with prosthesis shelloft, 1 case (11.11%) with hematoma and 4 cases (44.44%) with capsular contracture were observed. There were significant differences between two groups in the evidence of prosthesis shelloft and capsular contracture (P<0.05). All the patients were followed up for 1 year, no local recurrence and distant metastasis were observed. Conclusion Combination with prosthesis and dermal matrices had a better breast shape, higher satisfaction and less complication. It was a safer and more effective method of breast reconstruction.